Pmh74 - Quality of Life According to Temporal Illicit Opioid Use and Responder Rate in Adults Receiving Buprenorphine Depot Injections (Cam2038) to Treat Opioid Use Disorder in a 48-Week Open Label Study
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2885
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV